Ethena crosses $500M in cumulative revenue as synthetic stablecoins gain ground
While the overall stablecoin market is up 4% in August, some synthetic stablecoins, such as Sky Dollar and Falcon USD, have had even more substantial gains.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
While the overall stablecoin market is up 4% in August, some synthetic stablecoins, such as Sky Dollar and Falcon USD, have had even more substantial gains.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
UK Sets Crypto Licensing Rules as Treasury Plans to Exempt Some Stablecoin Payments
The UK’s Financial Conduct Authority published final guidance on Wednesday setting out which crypto activities will need its autho...
Bitcoin miners have amassed $100 billion of AI deals, but almost none of the revenue exists yet
Bitcoin miners have signed more than $100 billion in AI contracts while generating barely $1.1 billion in annualized revenue. More...
UK opens a major loophole for stablecoin payments while clamping down on crypto lending
HM Treasury has laid the final draft of the Financial Services and Markets Act 2000 (Cryptoassets) (Miscellaneous Amendments) Regu...
MEXC Releases July–August Security Report: Over 38 Million USDT in Risk-Related Funds Intercepted, Futures Insurance Fund Reaches 792 Million USDT
Mutsamudu, Comoros, September 16, 2026 – MEXC, a pioneer in 0-fee digital asset trading, has released its July–August 2026 securit...
Circle opens Arc mainnet as it seeks an edge for USDC utility
Circle has scheduled the public launch of Arc for Sept. 16, giving USDC a network where the same dollar balance can fund both paym...
XRP falls hard after CLARITY vote as Ripple’s regulatory advantage faces a new test
XRP fell more than 8% after the Senate blocked a key crypto bill, even as the token’s existing US regulatory treatment remained in...